Dialogue Health Technologies Inc.
DLHTFOTCHealthcare
$3.79
+$0.02(+0.59%)
Market Cap$254797554
P/E Ratio—
52W High$3.7922
52W Low$2.07
Dialogue Health Technologies Inc. (DLHTF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DLHTF · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Aug 14, 2023EPS Actual
-$0.09
Est. -$0.05 · -80.0%
Revenue
$0.02B
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Aug 14, 2023
After Market Close
▼ Miss EPS
DLHTF reports quarterly as a OTC-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q3 FY2023 | Aug 14, 2023 | -$0.05 | -$0.09 | -80.0% | $0.02B | — | — |
| ▼ Q1 FY2023 | Mar 21, 2023 | -$0.07 | -$0.08 | -14.3% | $0.02B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.05 | — | $0.01B | — | — |
| — Q4 FY2022 | Nov 14, 2022 | -$0.09 | -$0.09 | +0.0% | $0.02B | — | — |
| ▼ Q3 FY2022 | Aug 10, 2022 | -$0.10 | -$0.13 | -30.0% | $0.02B | — | — |
| ▼ Q2 FY2022 | May 9, 2022 | -$0.09 | -$0.11 | -22.2% | $0.02B | — | — |
| — Q4 FY2021 | Dec 31, 2021 | — | -$0.09 | — | $0.01B | — | — |
| — Q4 FY2021 | Nov 9, 2021 | -$0.09 | -$0.09 | +0.0% | $0.01B | — | — |
Q3 FY2023
Aug 14, 2023Miss
EPS Actual
-$0.09
EPS Est.
-$0.05
EPS Surpr.
-80.0%
Revenue
$0.02B
Q1 FY2023
Mar 21, 2023Miss
EPS Actual
-$0.08
EPS Est.
-$0.07
EPS Surpr.
-14.3%
Revenue
$0.02B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2022
Nov 14, 2022
EPS Actual
-$0.09
EPS Est.
-$0.09
EPS Surpr.
+0.0%
Revenue
$0.02B
Q3 FY2022
Aug 10, 2022Miss
EPS Actual
-$0.13
EPS Est.
-$0.10
EPS Surpr.
-30.0%
Revenue
$0.02B
Q2 FY2022
May 9, 2022Miss
EPS Actual
-$0.11
EPS Est.
-$0.09
EPS Surpr.
-22.2%
Revenue
$0.02B
Q4 FY2021
Dec 31, 2021
EPS Actual
-$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2021
Nov 9, 2021
EPS Actual
-$0.09
EPS Est.
-$0.09
EPS Surpr.
+0.0%
Revenue
$0.01B
No analyst estimates available for DLHTF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2023 | Aug 14, 2023 | -80.0% | $3.77 | $3.77 | +0.00% |
| ▼ Q1 FY2023 | Mar 21, 2023 | -14.3% | $2.07 | $2.07 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $2.07 | $2.07 | +0.00% |
| ▲ Q4 FY2022 | Nov 14, 2022 | +0.0% | $2.07 | $2.07 | +0.00% |
| ▼ Q3 FY2022 | Aug 10, 2022 | -30.0% | $2.30 | $2.30 | +0.00% |
| ▼ Q2 FY2022 | May 9, 2022 | -22.2% | No price data | $3.18 | — |
| — Q4 FY2021 | Dec 31, 2021 | — | No price data | $3.18 | — |
| ▲ Q4 FY2021 | Nov 9, 2021 | +0.0% | No price data | $3.18 | — |
Q3 FY2023+0.00%
Report Date
Aug 14, 2023
EPS Beat/Miss
-80.0%
Price Before
$3.77
Price After
$3.77
Q1 FY2023+0.00%
Report Date
Mar 21, 2023
EPS Beat/Miss
-14.3%
Price Before
$2.07
Price After
$2.07
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$2.07
Price After
$2.07
Q4 FY2022+0.00%
Report Date
Nov 14, 2022
EPS Beat/Miss
+0.0%
Price Before
$2.07
Price After
$2.07
Q3 FY2022+0.00%
Report Date
Aug 10, 2022
EPS Beat/Miss
-30.0%
Price Before
$2.30
Price After
$2.30
Q2 FY2022—
Report Date
May 9, 2022
EPS Beat/Miss
-22.2%
Price Before
—
Price After
$3.18
Q4 FY2021—
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$3.18
Q4 FY2021—
Report Date
Nov 9, 2021
EPS Beat/Miss
+0.0%
Price Before
—
Price After
$3.18
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate2 / 8 quarters
Largest Move+0.00% (Q3 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DLHTF ends December
Dialogue Health Technologies Inc. (DLHTF) most recently reported earnings on August 14, 2023 for Q3 FY2023, posting EPS of $-0.09 — missing the analyst consensus of $-0.05 by -80.0%. The next DLHTF earnings date is expected around September 1, 2026.
Each quarter, investors track DLHTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DLHTF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DLHTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DLHTF earnings · 5 questionsDialogue Health Technologies Inc.'s next earnings report is expected around September 1, 2026. DLHTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DLHTF historically reports after market close (AMC).
DLHTF earnings datewhen is DLHTF earningsDLHTF next earnings datewhen does DLHTF report earningsDLHTF earnings calendar
▸ Source: FMP · Dialogue Health Technologies Inc. SEC filings · US GAAP · Dialogue Health Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026